Latest news from across the biotech industry
The research collaboration agreement will further evaluate the Company’s proprietary adenosine analogs as a potential treatment for inflammatory diseases.
AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat inflammatory skin diseases.
A Multi-Enzyme Blend Was Tested and Validated in a Newly Adapted In Vitro Digestion Simulation Protocol
This is the company’s 5th FDA Clearance expanding the capabilities of its industry leading VitalStream™ wireless wearable.
The MicroGEM Sal6830 SARS-CoV-2 Saliva Test is the nation’s first point of care PCR saliva test for COVID-19, delivering results in minutes.
Dr. Tropsha will spearhead efforts to bring Contraline’s male contraceptive device, ADAM™, towards FDA approval
EIR expansion deepens BioHub’s bench of expertise to advance entrepreneurship in the regional ecosystem
Meet our new board members and learn about their goals for advancing the organization mission and growing the biotech industry in the region.
Hastings speaks about how plans for this inventive, cross-curricular specialized course of study in the M.S. in Commerce Program will offer students indispensable knowledge and learning experiences.
Results also indicate dual treatment of ZB131 with standard-of-care chemotherapy gemcitabine enhances suppression of tumor growth above chemotherapy alone in cholangiocarcinoma.
Blinded, interim data to be presented at the Undersea & Hyperbaric Medical Society’s Annual Scientific Meeting in May 2022.
Hamilton has lectured extensively around the world on a variety of topics including how to create a culture of innovation.